IMCoPharma’s regulatory team has successfully completed the registration of API Ifosfamide (IFOTAM Sp. z o. o., Poland) in Ukraine.
Ifosfamide is a cytotoxic drug in a form of powder for concentrate for infusion solutions treating malignant disease.
For more information about the products visit our sales portal imcobuy: www.imcobuy.com or contact us.